Cargando…
GPR40 (FFAR1) – Combined Gs and Gq signaling in vitro is associated with robust incretin secretagogue action ex vivo and in vivo
OBJECTIVES: GPR40 (FFAR1), a clinically proven anti-diabetes target, is a Gq-coupled receptor for long chain fatty acids (LCFA) stimulating insulin secretion directly and mediating a major part of the dietary triglyceride-induced secretion of the incretins GLP-1 and GIP. In phase-II studies the GPR4...
Autores principales: | Hauge, Maria, Vestmar, Marie A., Husted, Anna S., Ekberg, Jeppe P., Wright, Michael J., Di Salvo, Jerry, Weinglass, Adam B., Engelstoft, Maja S., Madsen, Andreas N., Lückmann, Michael, Miller, Michael W., Trujillo, Maria E., Frimurer, Thomas M., Holst, Birgitte, Howard, Andrew D., Schwartz, Thue W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314522/ https://www.ncbi.nlm.nih.gov/pubmed/25685685 http://dx.doi.org/10.1016/j.molmet.2014.10.002 |
Ejemplares similares
-
Optimization
of First-in-Class Dual-Acting FFAR1/FFAR4
Allosteric Modulators with Novel Mode of Action
por: Lückmann, Michael, et al.
Publicado: (2022) -
Molecular dynamics-guided discovery of an ago-allosteric modulator for GPR40/FFAR1
por: Lückmann, Michael, et al.
Publicado: (2019) -
Autocrine negative feedback regulation of lipolysis through sensing of NEFAs by FFAR4/GPR120 in WAT
por: Husted, Anna Sofie, et al.
Publicado: (2020) -
Free fatty acid receptor 1 stimulates cAMP production and gut hormone secretion through Gq-mediated activation of adenylate cyclase 2
por: Petersen, Jacob Emil, et al.
Publicado: (2023) -
Targeted intestinal delivery of incretin secretagogues—towards new diabetes and obesity therapies
por: Gribble, Fiona M., et al.
Publicado: (2018)